Mucormycosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 12: | Line 12: | ||
{{CMG}}; {{AE}}{{HK}} | {{CMG}}; {{AE}}{{HK}} | ||
{{SK}} Mucormycosis, Mucor, rhino-cerebral mucormycosis, pulmonary mucorycosis, cutaneous mucormycosis, gastrointestinal mucormycosis | {{SK}} Mucormycosis, Mucor infection, rhino-cerebral mucormycosis, pulmonary mucorycosis, cutaneous mucormycosis, gastrointestinal mucormycosis | ||
==[[Mucormycosis overview|Overview]]== | ==[[Mucormycosis overview|Overview]]== |
Revision as of 19:37, 14 June 2017
Mucormycosis | |
Necrotic tissue in rhnocerebral mucormycosis. |
Mucormycosis Microchapters |
Diagnosis |
---|
Treatment |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Synonyms and keywords: Mucormycosis, Mucor infection, rhino-cerebral mucormycosis, pulmonary mucorycosis, cutaneous mucormycosis, gastrointestinal mucormycosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mucormycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies